Also written by Berkeley Lovelace Jr.:
Bristol-Myers Urges Shareholders in Open Letter to Support $74 Billion Celgene Deal Amid Resistance
x hide permanently

Billionaire Early Facebook Investor Calls for 'Radical Change,' But Still Stands by Zuckerberg

"I would back and invest again and again in Mark Zuckerberg," says Jim Breyer, an early investor and former board member...

Mentions: Facebook Mark Zuckerberg Wall Street